- Home
- UNH vs ABBV Comparison
UNH vs ABBV Comparison
Compare UNH & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNH
- ABBV
- Stock Information
- Founded
- UNH 1977
- ABBV 2012
- Country
- UNH United States
- ABBV United States
- Employees
- UNH N/A
- ABBV N/A
- Industry
- UNH Medical Specialities
- ABBV Biotechnology: Pharmaceutical Preparations
- Sector
- UNH Health Care
- ABBV Health Care
- Exchange
- UNH Nasdaq
- ABBV Nasdaq
- Market Cap
- UNH 315.1B
- ABBV 365.1B
- IPO Year
- UNH 1984
- ABBV N/A
- Fundamental
- Price
- UNH $370.09
- ABBV $231.83
- Analyst Decision
- UNH Buy
- ABBV Buy
- Analyst Count
- UNH 25
- ABBV 24
- Target Price
- UNH $403.13
- ABBV $227.18
- AVG Volume (30 Days)
- UNH 10.2M
- ABBV 6.7M
- Earning Date
- UNH 10-28-2025
- ABBV 10-31-2025
- Dividend Yield
- UNH 2.39%
- ABBV 2.84%
- EPS Growth
- UNH 52.72
- ABBV N/A
- EPS
- UNH 23.12
- ABBV 2.10
- Revenue
- UNH $422,818,000,000.00
- ABBV $58,328,000,000.00
- Revenue This Year
- UNH $13.02
- ABBV $9.85
- Revenue Next Year
- UNH $3.95
- ABBV $8.98
- P/E Ratio
- UNH $16.00
- ABBV $110.11
- Revenue Growth
- UNH 9.70
- ABBV 6.05
- 52 Week Low
- UNH $234.60
- ABBV $163.81
- 52 Week High
- UNH $630.73
- ABBV $244.81
- Technical
- Relative Strength Index (RSI)
- UNH 74.36
- ABBV 60.84
- Support Level
- UNH $341.63
- ABBV $227.59
- Resistance Level
- UNH $368.00
- ABBV $234.08
- Average True Range (ATR)
- UNH 7.89
- ABBV 5.24
- MACD
- UNH 0.72
- ABBV -0.11
- Stochastic Oscillator
- UNH 86.96
- ABBV 51.36
About UNH UnitedHealth Group
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).